Posted on June 21, 2011
Deadline: August 25, 2011 (Letters of Intent)

Alzheimer's Drug Discovery Foundation and the Association for Frontotemporal Degeneration Invite Scientists to Apply for FTD Biomarkers Grants

The Alzheimer's Drug Discovery Foundation and the Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants and program-related investments to develop Frontotemporal Dementia-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.

The ADDF and AFTD are particularly interested in defining and validating clinical outcomes for FTD subpopulations for use in clinical trials; FTD-relevant imaging agents; CSF- and plasma-based assays; and TDP-43 and tau-focused biomarkers specifically relevant to FTD populations.

The biomarker program will provide one-year grants of up to $150,000 with the possibility of follow-on funding.

Applications may be submitted by nonprofit academic institutions and for-profit biotechnology companies, both public and private, worldwide. Please note that funding to biotechnology companies is typically made as a program-related investment.

For complete program guidelines and application procedures, visit the Alzheimer's Drug Discovery Foundation Web site.

Contact:
Link to Complete RFP

Primary Subject: Medical Research
Geographic Funding Area: National

Looking for additional funders in the field of Medical Research?
Foundation Directory Online allows you to search the entire universe of U.S. grantmakers. Target your search by field of interest, type of support, geographic focus, and more. Find the plan that's right for you»